Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis
Authors
Keywords
Perfusion, Magnetic resonance imaging, Glioma, Biomarker, Predictive, Prognostic, Pharymacodynamic
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 128, Issue 2, Pages 185-194
Publisher
Springer Nature
Online
2016-04-23
DOI
10.1007/s11060-016-2102-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How Treatment Monitoring Is Influencing Treatment Decisions in Glioblastomas
- (2015) Martha R. Neagu et al. Current Treatment Options in Neurology
- MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab
- (2015) Robert J. Harris et al. JOURNAL OF NEURO-ONCOLOGY
- Central Nervous System Cancers, Version 1.2015
- (2015) Louis Burt Nabors et al. Journal of the National Comprehensive Cancer Network
- Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial
- (2015) Kathleen M. Schmainda et al. NEURO-ONCOLOGY
- Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma
- (2015) Philipp Kickingereder et al. NEURO-ONCOLOGY
- Metrology Standards for Quantitative Imaging Biomarkers
- (2015) Daniel C. Sullivan et al. RADIOLOGY
- Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab
- (2014) Philipp Kickingereder et al. JOURNAL OF NEURO-ONCOLOGY
- Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
- (2014) K. M. Schmainda et al. NEURO-ONCOLOGY
- Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
- (2014) Domenico Aquino et al. PLoS One
- Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab
- (2014) Kevin Leu et al. CANCER IMAGING
- Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial
- (2013) Alvin R. Cabrera et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Exploratory Evaluation of MR Permeability with 18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium
- (2013) K. A. Zukotynski et al. JOURNAL OF NUCLEAR MEDICINE
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy
- (2011) Whitney B. Pope et al. Current Neurology and Neuroscience Reports
- Model-based, semiquantitative and time intensity curve shape analysis of dynamic contrast-enhanced MRI: A comparison in patients undergoing antiangiogenic treatment for recurrent glioma
- (2011) Cristina Lavini et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
- (2011) T. N. Kreisl et al. NEURO-ONCOLOGY
- Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System
- (2010) Victor A. Levin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
- (2010) Sridharan Gururangan et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic versus predictive value of biomarkers in oncology
- (2008) C.N.A.M. Oldenhuis et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started